# Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults

> **NCT01162590** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 52 (actual)

## Conditions studied

- Infections, Rotavirus

## Interventions

- **BIOLOGICAL:** Rotarix ™
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01162590
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-01
- **Primary completion:** 2010-03-31
- **Final completion:** 2010-03-31
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01162590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01162590, "Study to Evaluate the Reactogenicity and Safety of Rotarix™ in Chinese Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01162590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*